Get access to our best features
Get access to our best features
Published

IPAY 2027 Negotiated Drugs Expand Impact on Beneficiaries

Summary by Avalere Health
On January 17, the Centers for Medicare & Medicaid Services (CMS) released the list of the next 15 Part D drugs that have been selected for Medicare negotiation for Initial Price Applicability Year (IPAY) 2027. This list follows the first 10 selected drugs for IPAY 2026. While MFPs will apply specifically to the 25 selected drugs, they may also impact the competitive dynamics between these drugs and their therapeutic alternatives. With more drug…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)